Adult Hemoglobinopathy Testing Market - Global Forecast 2026-2032

Senior decision-makers in the clinical diagnostics sector recognize that adult hemoglobinopathy testing is central to providing timely, accurate care for adult patients with inherited blood disorders. As diagnostic requirements intensify alongside laboratory automation and regulatory demands, understanding how integrated testing strategies can strengthen operational efficiency and patient outcomes has never been more critical.

Market Snapshot: Adult Hemoglobinopathy Testing Market Trends

The Adult Hemoglobinopathy Testing Market advanced from USD 5.34 billion in 2025 to USD 5.58 billion in 2026 and is projected to expand at a CAGR of 6.22%, reaching USD 8.14 billion by 2032. This growth is powered by evolving clinical guidelines, a shift toward hybrid laboratory and point-of-care workflows, and increased investments in molecular diagnosis capabilities. The sector is adapting to accommodate both rising demand and the operational imperatives of accuracy, speed, and seamless integration into clinical care pathways.

Scope & Segmentation

Testing Modalities: Laboratory-based techniques, such as electrophoresis, high performance liquid chromatography (HPLC), and molecular genetic analysis, are complemented by point-of-care rapid tests for front-line screening.
Disease Subtypes: Solutions address the diagnostic needs of hemoglobin C disease, sickle cell disease, and the full spectrum of thalassemia variants, with specialized focus on alpha, beta, and delta subtypes requiring targeted molecular and hematologic methods.
End-User Capabilities: Distinct operating contexts include diagnostic and reference labs, hospital laboratories spanning secondary through tertiary care, and research institutes engaged in assay development and validation.
Distribution Channels: Commercial pathways include direct sales, established distributor networks (local and regional partners), and digital/online vendor models.
Region Coverage: Analysis spans the Americas, Europe, the Middle East & Africa, and the Asia-Pacific, capturing diverse regulatory, reimbursement, and infrastructure landscapes.

Key Takeaways

Integrated diagnostic strategies now prioritize streamlined workflows and improved turnaround time, enabling clinical teams to move seamlessly from rapid screening to laboratory confirmation and genetic subtyping.
The operational complexity in adult hemoglobinopathy testing is compounded by the necessity to align evolving disease classifications with optimal test selection and result interpretation.
Advancements in laboratory informatics and interoperability are shaping how clinical data flows between labs and care teams, supporting real-time decision-making and patient management.
Point-of-care tests are supplementing traditional laboratory approaches, extending reach into underserved regions and reducing referral burdens for initial screening while preserving laboratory confirmation for diagnostic certainty.
Disease-focused segmentation creates opportunities to tailor molecular and biochemical assays to specific clinical and operational needs, enhancing the relevance and uptake of diagnostic solutions.

Tariff Impact on Supply Chain and Procurement

Recent tariff adjustments in the United States have materially influenced procurement strategies, supply chain resilience, and inventory planning for hemoglobinopathy diagnostics. Distributors and manufacturers now emphasize local sourcing and closer supplier relationships, aiming to control incremental costs and mitigate extended lead times for critical reagents and instrumentation. Strategic decisions are focusing on nearshoring component production, strategic buffering of critical supplies, and diversified supplier portfolios to maintain continuity of diagnostic services while adapting to a fluctuating cost environment.

Methodology & Data Sources

This report employs a mixed-method research approach combining primary stakeholder interviews, laboratory validation reviews, and synthesis of regulatory and technical literature. Direct engagement with laboratory directors, procurement leaders, developers, and channel partners brings operational realities and adoption challenges to the fore. Secondary sources and structured frameworks ensure a rigorous, triangulated perspective on the adult hemoglobinopathy testing landscape.

Why This Report Matters: Adult Hemoglobinopathy Testing Market

Gain strategic clarity on technology options, supply chain resilience, and market entry models that suit diverse laboratory and healthcare network needs.
Support informed decisions regarding investment in interoperable platforms, regional partnerships, and clinical education initiatives to drive sustainable adoption.

Conclusion

Coordinated diagnostic workflows, robust supply planning, and collaborative commercial approaches are essential for advancing adult hemoglobinopathy testing. Stakeholders who effectively align innovation, operations, and clinician engagement will be best positioned to deliver reliable diagnostics and improved patient outcomes.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Adult Hemoglobinopathy Testing Market, by Modality

8.1. Laboratory Based Tests
8.1.1. Electrophoresis
8.1.2. Genetic Analysis
8.1.3. High Performance Liquid Chromatography
8.2. Point Of Care Tests

9. Adult Hemoglobinopathy Testing Market, by Disease Type

9.1. Hemoglobin C Disease
9.2. Sickle Cell Disease
9.3. Thalassemia
9.3.1. Alpha Thalassemia
9.3.2. Beta Thalassemia
9.3.3. Delta Thalassemia

10. Adult Hemoglobinopathy Testing Market, by Distribution Channel

10.1. Direct Sales
10.2. Distributors
10.2.1. Local Distributors
10.2.2. Regional Distributors
10.3. Online Vendors

11. Adult Hemoglobinopathy Testing Market, by End User

11.1. Diagnostic Laboratories
11.1.1. Hospital Laboratories
11.1.2. Independent Laboratories
11.1.3. Reference Laboratories
11.2. Hospitals
11.2.1. Secondary Care Hospitals
11.2.2. Tertiary Care Hospitals
11.3. Research Institutes

12. Adult Hemoglobinopathy Testing Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Adult Hemoglobinopathy Testing Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Adult Hemoglobinopathy Testing Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Adult Hemoglobinopathy Testing Market
16. China Adult Hemoglobinopathy Testing Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. ARKRAY, Inc.
17.7. Beckman Coulter, Inc. by Danaher Corporation
17.8. Becton, Dickinson and Company
17.9. Bio-Rad Laboratories, Inc.
17.10. Bluebird Bio, Inc.
17.11. Creative Diagnostics
17.12. Danaher Corporation
17.13. F. Hoffmann-La Roche Ltd.
17.14. HORIBA Group
17.15. Illumina, Inc.
17.16. Laboratory Corporation of America Holdings
17.17. Merck KGaA
17.18. Ortho Clinical Diagnostics Inc.
17.19. PerkinElmer, Inc.
17.20. Quest Diagnostics Incorporated
17.21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.22. Shimadzu Corporation
17.23. Siemens Healthineers AG
17.24. Sysmex Corporation
17.25. Thermo Fisher Scientific Inc.
17.26. Tosoh Corporation
17.27. Trinity Biotech PLC

List of Figures

FIGURE 1. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ELECTROPHORESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ELECTROPHORESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GENETIC ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GENETIC ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GENETIC ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HEMOGLOBIN C DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HEMOGLOBIN C DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HEMOGLOBIN C DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SICKLE CELL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SICKLE CELL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ALPHA THALASSEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ALPHA THALASSEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ALPHA THALASSEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY BETA THALASSEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY BETA THALASSEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY BETA THALASSEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DELTA THALASSEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DELTA THALASSEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DELTA THALASSEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ONLINE VENDORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ONLINE VENDORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ONLINE VENDORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 124. EUROPE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. EUROPE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 126. EUROPE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 128. EUROPE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 129. EUROPE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. EUROPE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 131. EUROPE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. EUROPE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 133. EUROPE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 144. AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 146. AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 147. AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 148. AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 149. AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 151. AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 153. AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. ASEAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. ASEAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 167. ASEAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 168. ASEAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 169. ASEAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 170. ASEAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. ASEAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 172. ASEAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. ASEAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 174. ASEAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 175. GCC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GCC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 177. GCC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 178. GCC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 179. GCC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 180. GCC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. GCC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 182. GCC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. GCC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 184. GCC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 195. BRICS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. BRICS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 197. BRICS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 198. BRICS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 199. BRICS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 200. BRICS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 201. BRICS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 202. BRICS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. BRICS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 204. BRICS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 205. G7 ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. G7 ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 207. G7 ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 208. G7 ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 209. G7 ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 210. G7 ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. G7 ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 212. G7 ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. G7 ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 214. G7 ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 215. NATO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. NATO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 217. NATO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 218. NATO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 219. NATO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 220. NATO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. NATO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 222. NATO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. NATO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 224. NATO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 236. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 237. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 238. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2032 (USD MILLION)
TABLE 239. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 240. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2032 (USD MILLION)
TABLE 241. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 243. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 245. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Adult Hemoglobinopathy Testing market report include:

Abbott Laboratories
ARKRAY, Inc.
Beckman Coulter, Inc. by Danaher Corporation
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bluebird Bio, Inc.
Creative Diagnostics
Danaher Corporation
F. Hoffmann-La Roche Ltd.
HORIBA Group
Illumina, Inc.
Laboratory Corporation of America Holdings
Merck KGaA
Ortho Clinical Diagnostics Inc.
PerkinElmer, Inc.
Quest Diagnostics Incorporated
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shimadzu Corporation
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific Inc.
Tosoh Corporation
Trinity Biotech PLC

Table Information

Report Attribute	Details
No. of Pages	182
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 5.58 Billion
Forecasted Market Value ( USD ) by 2032	$ 8.14 Billion
Compound Annual Growth Rate	6.2%
Regions Covered	Global
No. of Companies Mentioned	24

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3513EUR$3,939USD£3,047GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3789EUR$4,249USD£3,286GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5136EUR$5,759USD£4,454GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6215EUR$6,969USD£5,390GBP

Market Snapshot: Adult Hemoglobinopathy Testing Market Trends

Scope & Segmentation

Key Takeaways

Tariff Impact on Supply Chain and Procurement

Methodology & Data Sources

Why This Report Matters: Adult Hemoglobinopathy Testing Market

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Adult Hemoglobinopathy Testing - Global Strategic Business Report

Beta Thalassemia Testing Market - Global Forecast 2026-2032

Hemoglobin Testing Market - Global Forecast 2026-2032

Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report

Hemoglobin A1c (HbA1c) Testing Market Report 2025